tiprankstipranks
Rubicon Organics Inc (DE:R07)
FRANKFURT:R07
Germany Market

Rubicon Organics (R07) Earnings Dates, Call Summary & Reports

0 Followers

Earnings Data

Report Date
Aug 13, 2026
TBA (Not Confirmed)
Period Ending
2026 (Q2)
Consensus EPS Forecast
>-0.01
Last Year’s EPS
<0.01
Same Quarter Last Year
Moderate Buy
Based on 2 Analysts Ratings

Earnings Call Summary

Q2 2025
Earnings Call Date:Aug 18, 2025|
% Change Since:
|
Earnings Call Sentiment|Positive
Rubicon Organics demonstrated strong performance in Q2 2025 with record-breaking revenue growth, improved gross margins, and positive cash flow. Strategic expansion and innovation in product offerings indicate a solid position for future growth. However, the company faces challenges with share erosion in topicals, licensing delays for a new facility, and inventory management.
Company Guidance
During Rubicon Organics' Q2 2025 earnings call, the company reported record net revenue of $15 million, marking a 24% increase year-over-year and a 21% sequential rise. Gross profit reached $5.9 million with a gross margin of 34%, up from 30% the previous year. Adjusted EBITDA was $1.4 million, contributing to a year-to-date total of $2.1 million. The company's growth was driven by its expanding 1964 brand, particularly in the pre-roll and vape segments, which saw a significant increase in SKUs and captured over 15% of the market. Rubicon also maintained a strong presence in premium edibles and topicals, holding the #1 position in premium edibles and #2 in topicals. The company completed a $4.5 million private placement and finalized the acquisition of its Hope facility to increase production capacity by 40%, positioning itself for further growth amid a global cannabis supply shortage. Rubicon closed the quarter with $7.3 million in cash and $18.7 million in working capital, supported by disciplined cost control and a prudent capital structure.
Record-Breaking Revenue and Growth
Rubicon Organics delivered a record net revenue of $15 million in Q2 2025, marking the highest ever for a single quarter, up 24% year-over-year and 21% sequentially.
Strong Performance Across Key Segments
The 1964 brand saw strong growth led by the pre-roll segment. The 510 live resin line, launched in Q2 2024, continued to gain momentum. Simply Bare Organic also delivered growth, driven by strong pre-roll sales.
Gross Margin Improvement
Gross profit before fair value adjustments was $5.1 million, up 40% from Q2 2024, with gross margin improving to 34% compared to 30% a year ago.
Positive Cash Flow and Financial Health
The company generated $800,000 in cash from operating activities in Q2 2025, compared to an operating cash outflow of $300,000 in Q2 2024. The quarter closed with $7.3 million in cash and a solid working capital position of $18.7 million.
Strategic Expansion with New Facility
The acquisition of the new facility in Hope, BC, is expected to increase production capacity by over 40%, positioning Rubicon Organics for long-term growth.
Innovation in Product Offerings
Launched BC Organic Sunset Runtz and the first all-in-one resin vape under the Comatose strain, contributing to product diversity and growth.
Strong Brand Positioning in Market
Rubicon holds the #1 position in premium edibles and continues to lead in the topical category with market's top-selling SKU.

Rubicon Organics (DE:R07) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

DE:R07 Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Aug 13, 2026
2026 (Q2)
>-0.01 / -
0.006
May 14, 2026
2026 (Q1)
-0.02 / -0.02
-0.006-300.00% (-0.02)
Mar 24, 2026
2025 (Q4)
<0.01 / -0.02
0
Nov 12, 2025
2025 (Q3)
<0.01 / 0.02
0
Aug 18, 2025
2025 (Q2)
<0.01 / <0.01
-0.006200.00% (+0.01)
May 27, 2025
2025 (Q1)
- / >-0.01
-0.01966.67% (+0.01)
Apr 02, 2025
2024 (Q4)
- / >-0.01
-0.01966.67% (+0.01)
Nov 14, 2024
2024 (Q3)
- / 0.00
-0.018
Aug 15, 2024
2024 (Q2)
- / >-0.01
0
May 16, 2024
2024 (Q1)
- / -0.02
-0.006-200.00% (-0.01)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

DE:R07 Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
May 14, 2026
€0.29€0.30+0.68%
Mar 24, 2026
€0.29€0.290.00%
Nov 12, 2025
€0.32€0.31-3.77%
Aug 18, 2025
€0.36€0.33-8.94%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Rubicon Organics Inc (DE:R07) report earnings?
Rubicon Organics Inc (DE:R07) is schdueled to report earning on Aug 13, 2026, TBA (Not Confirmed).
    What is Rubicon Organics Inc (DE:R07) earnings time?
    Rubicon Organics Inc (DE:R07) earnings time is at Aug 13, 2026, TBA (Not Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is the P/E ratio of Rubicon Organics Inc stock?
          The P/E ratio of Rubicon Organics is N/A.
            What is DE:R07 EPS forecast?
            DE:R07 EPS forecast for the fiscal quarter 2026 (Q2) is >-0.01.